Dr. Manish Reddy Kanukunta, MD

Dr. Kanukunta practices at West Henderson Hospital in Henderson, Nevada, part of Universal Health Services.

Dr. Kanukunta's NPI, 1629655113, was assigned on March 29, 2021. Dr. Kanukunta holds Nevada license 25329.

Dr. Kanukunta's primary practice is West Henderson Hospital, at 1155 Raiders Way, Henderson, NV 89052 in Clark County. The practice phone is (702) 369-7612.

Dr. Kanukunta's primary practice is West Henderson Hospital in Henderson, Nevada, part of Universal Health Services. Dr. Kanukunta is also affiliated with Dignity Health - Saint Rose Dominican Hospital, Siena Campus. The medical group on file is Platinum Hospitalists. Dmand AI also links Dr. Kanukunta to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kanukunta practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kanukunta's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kanukunta is licensed in Nevada.

CMS data shows 567 Medicare services from Dr. Kanukunta across 5 procedure codes in 2024, for 233 Medicare patients. Medicare paid $47,155 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 233 Medicare patients who saw Dr. Kanukunta in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kanukunta's median patient age at 73, with 53% women.

In 2024, Dr. Kanukunta wrote 157 Medicare Part D claims for 64 patients. 86% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $335 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 61 out of 100 for Dr. Kanukunta for performance year 2024, reported as part of a group. Dr. Kanukunta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Kanukunta from 2 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $24.